HomeInvestingEarningsTrading Moderna (MRNA), Regeneron (REGN) Following Strong 2Q Results
Trading Moderna (MRNA), Regeneron (REGN) Following Strong 2Q Results

Brad Loncar discusses the rallies in both Moderna and Regeneron following their quarterly results. Moderna's earnings and revenue blew past expectation, despite the company warning of declining profit as a result of unused Covid-19 vaccines. Regeneron also beat on top and bottom line, amid record sales of several of its products. Tom White then breaks down a bullish example trade in Moderna and a neutral to bullish trade in Regeneron.

ON AIR
12:00 am
Fast Market
replay
ON AIR
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
education
9:30 am
Your First Trade
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
education
4:30 pm
Your First Trade
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
education
8:00 pm
Your First Trade
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US